CRISPR-based innovations drove $21 billion in pharmaceutical licensing deals over five years: GlobalData, ET HealthWorldby India News Online Team April 10, 2024 0 London: The pharmaceutical industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology over the past five years. ...